Lv62
2830 积分 2024-06-18 加入
Biologic degraders push forward in the clinic
6天前
已完结
Hallmarks of cancer research: Enabling transformative discovery through global team science
22天前
已完结
Accelerated drug discovery by rapid candidate drug identification
23天前
已完结
Intracellular and Intraorgan Concentrations of Small Molecule Drugs: Theory, Uncertainties in Infectious Diseases and Oncology, and Promise
25天前
已完结
Property-based optimisation of PROTACs
1个月前
已完结
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
1个月前
已完结
Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis
1个月前
已完结
Whatever happened to cassette-dosing pharmacokinetics?
1个月前
已完结
The Affinity Advantage
2个月前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
2个月前
已完结
皖公网安备34019202002308
